ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,306.04
      0.02%
      US Tech 100
      18,375.20
      0.31%
      Dow Jones
      38,852.86
      -0.55%
      Brent Oil
      84.185
      -0.17%
      Bitcoin
      68,746.26
      0.67%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Zentalis Pharmaceuticals Inc (ZNTL)

      7. Zentalis Pharmaceuticals Inc (ZNTL) News

      ZNTL

      Zentalis Pharmaceuticals (ZNTL)

      Zentalis Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ZNTL
      DateTimeSourceHeadlineSymbolCompany
      05/23/20245:01PMGlobeNewswire Inc.Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitabine in Relapsed or Refractory Osteosarcoma at 2024 American Society of Clinical Oncology Annual MeetingNASDAQ:ZNTLZentalis Pharmaceuticals Inc
      05/14/20247:00AMGlobeNewswire Inc.Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation SummitNASDAQ:ZNTLZentalis Pharmaceuticals Inc
      05/07/20247:05AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ZNTLZentalis Pharmaceuticals Inc
      05/07/20247:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZNTLZentalis Pharmaceuticals Inc
      05/07/20247:00AMGlobeNewswire Inc.Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational ProgressNASDAQ:ZNTLZentalis Pharmaceuticals Inc
      05/01/20245:30PMGlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
      04/02/20244:05PMGlobeNewswire Inc.Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024NASDAQ:ZNTLZentalis Pharmaceuticals Inc
      04/01/20245:30PMGlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
      03/01/20246:00PMGlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
      02/29/20245:20PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ZNTLZentalis Pharmaceuticals Inc
      02/29/20245:14PMEdgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:ZNTLZentalis Pharmaceuticals Inc
      02/28/20247:00AMGlobeNewswire Inc.Zentalis Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
      02/27/20247:08AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ZNTLZentalis Pharmaceuticals Inc
      02/27/20247:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZNTLZentalis Pharmaceuticals Inc
      02/27/20247:00AMGlobeNewswire Inc.Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational UpdatesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
      02/15/20244:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZNTLZentalis Pharmaceuticals Inc
      02/13/20247:43PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ZNTLZentalis Pharmaceuticals Inc
      02/13/20247:00AMGlobeNewswire Inc.Zentalis Pharmaceuticals to Participate in the Oppenheimer Healthcare Life Sciences ConferenceNASDAQ:ZNTLZentalis Pharmaceuticals Inc
      02/12/20248:25PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
      02/12/20248:25PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
      02/12/20248:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
      02/05/20247:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
      02/05/20247:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
      02/05/20247:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
      02/05/20247:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
      02/02/20249:29PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
      02/02/20249:29PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
      02/02/20249:28PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
      02/02/20249:27PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
      02/02/20249:26PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:ZNTL